Low cholesterol levels are good markers for central
hypothyroidism in case with dialysis using roxadustat
Serina Kita1,Hiroshi
Okuyama2,Takaya Kondo1,Mizuki
Hayashi1,Shinichiro
Nakao1,Toshitaka Sawamura2,Keiji
Fujimoto1,Atsushi
Nakagawa3,Hitoshi Yokoyama1,Kengo
Furuichi1
Department of Nephrology, Kanazawa Medical
University1,Asanogawa General
Hospital2,Department of Diabetology and
endocrinology, Kanazawa Medical University3
Corresponding author Kengo Furuichi
Kanazawa Medical University Department of Nephrology
1-1 Daigaku, Uchinada, Kahoku, Ishikawa 920-0293, Japan
tel +81-76-286-2211 (ext 33401)
fax +81-76-286-2786 E-mail: furuichi@kanazawa-med.ac.jp
Keywords: hypoxia-inducible factor prolyl hydroxylase (HIF-PH)
inhibitors, low cholesterol levels, roxadustat, central hypothyroidism
Patient consent statement: Written informed consent was obtained
from the patient to publish this report in accordance with the
journal’spatient consent policy.